Chemotherapy and Urological Malignancy

1. Front Matter

   Pages i-xvii

   PDF

2. Chemotherapy of Adrenal Cortical Carcinoma

   • J. Zeffren, A. Yagoda

   Pages 1-8

3. Cytotoxic Drugs and Hormonal Manipulations in the Management of Carcinoma of the Kidney

   • A. S. D. Spiers

   Pages 9-26

4. The Management of Wilms’ Tumor

   • J. E. Champion, J. Wilimas, A. P. M. Kumar

   Pages 27-43

5. Primary Carcinoma of the Renal Pelvis and Ureter

   • B. S. Kasimis

   Pages 44-49

6. Intravesical Chemotherapy for Superficial Bladder Cancer

   • M. S. Soloway

   Pages 50-71

7. Chemotherapy for Advanced Urothelial Tract Tumors

   • A. Yagoda

   Pages 72-79

8. Chemotherapy of Cancer of the Prostate

   • F. M. Torti, S. K. Carter

   Pages 80-96

9. Penile Cancer: Natural History and Therapy

   • R. B. Sklaroff, Alan Yagoda

   Pages 97-105

10. Primary Carcinomas of the Male and Female Urethra: Other Rare Forms of Urothelial Cancer

    • B. S. Kasimis

    Pages 106-114

11. Chemotherapy of Testicular Cancer

    • L. H. Einhorn, S. D. Williams

    Pages 115-125

12. Urological Oncology — A European View

    • P. H. Smith

    Pages 126-150

13. Future Progress in Chemotherapy of Urological Tumors

    • A. S. D. Spiers

    Pages 151-154

14. Back Matter

    Pages 155-163

    PDF

Chemotherapy for malignant disease has brought about many rapid and often spectacular improvements in the survival rate of some groups of patients. Yet enthusiasm for these successes has, in part, been offset by the problems in evaluating responses to treatment and by the disappointment of failing to check the progress of still so many other tumours. These reactions will be no surprise to the medical historian but perhaps the expectations from scientific progress nowadays sometimes demand more than can reasonably be expected. Another expectation is that any review of chemotherapy is com­ pletely up to date, even prophetic. Such is the expansion of the subject that new drugs and trial results are continually being reported but it is this very mass of information that creates its own problems and makes many clinicians despair of finding a balanced judgement on all of this information. This was the challenge accepted by Professor Spiers. He then gathered together a group of colleagues who are amongst the acknowledged leaders in the field of chemotherapy for urological tumours, all of whom have made important contributions to this subject. However, each chapter is not merely a record of the author's experience but encompasses an assessment of past and present practice as well as perspectives in diagnosis and management. Almost all chapters include reference to published work up to and including 1981.

• Urogenitalkrebs
• Zytostatikum
• cancer
• carcinoma
• chemotherapy
• kidney
• prostate
• tumor

• Division of Oncology, The Albany Medical College, Albany, USA

  A. S. D. Spiers

Policies and ethics